Codexis, Inc. (LON: 0I0X)

Market Cap	321.78M
Revenue (ttm)	48.08M
Net Income (ttm)	-46.33M
Shares Out	n/a
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,483
Average Volume	2,731
Open	5.02
Previous Close	5.18
Day's Range	5.00 - 5.12
52-Week Range	1.47 - 5.12
Beta	2.07
RSI	52.54
Earnings Date	Feb 28, 2025

About Codexis

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company’s platform is also used f...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 174
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I0X

Financial Performance

In 2023, Codexis's revenue was $70.14 million, a decrease of -49.39% compared to the previous year's $138.59 million. Losses were -$76.24 million, 127.0% more than in 2022.

Financial numbers in USD